DK359486D0 - Overfoerbare pattedyrgener forbundet med tumormetastase, fremg. til isolering deraf, proteiner som generne koder for, antistoffer over for disse, sonder for generne og for mrna transkriberet derfra og fremg. til bedoemmelse af tumorers metastatiske tilboejelighed - Google Patents
Overfoerbare pattedyrgener forbundet med tumormetastase, fremg. til isolering deraf, proteiner som generne koder for, antistoffer over for disse, sonder for generne og for mrna transkriberet derfra og fremg. til bedoemmelse af tumorers metastatiske tilboejelighedInfo
- Publication number
- DK359486D0 DK359486D0 DK359486A DK359486A DK359486D0 DK 359486 D0 DK359486 D0 DK 359486D0 DK 359486 A DK359486 A DK 359486A DK 359486 A DK359486 A DK 359486A DK 359486 D0 DK359486 D0 DK 359486D0
- Authority
- DK
- Denmark
- Prior art keywords
- genes
- metastase
- forget
- metastatic
- tumors
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title 4
- 206010028980 Neoplasm Diseases 0.000 title 2
- 206010027476 Metastases Diseases 0.000 title 1
- 230000001394 metastastic effect Effects 0.000 title 1
- 206010061289 metastatic neoplasm Diseases 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
- G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67662584A | 1984-11-30 | 1984-11-30 | |
| PCT/US1985/002323 WO1986003226A1 (en) | 1984-11-30 | 1985-11-26 | Transmissible, mammalian genes associated with tumor metastasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK359486A DK359486A (da) | 1986-07-29 |
| DK359486D0 true DK359486D0 (da) | 1986-07-29 |
Family
ID=24715276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK359486A DK359486D0 (da) | 1984-11-30 | 1986-07-29 | Overfoerbare pattedyrgener forbundet med tumormetastase, fremg. til isolering deraf, proteiner som generne koder for, antistoffer over for disse, sonder for generne og for mrna transkriberet derfra og fremg. til bedoemmelse af tumorers metastatiske tilboejelighed |
Country Status (13)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5049662A (en) * | 1987-10-13 | 1991-09-17 | The United States Of America As Represented By The Department Of Health And Human Services | Kit for diagnosing cancer metastatic potential |
| EP0495910B1 (en) | 1989-10-18 | 2001-09-26 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Production and use of human nm23-h2 protein and antibodies therefor |
| US6825320B1 (en) | 1995-03-29 | 2004-11-30 | Millenium Pharmaceuticals, Inc. | FOHY03 polypeptides |
| US5633161A (en) * | 1995-03-29 | 1997-05-27 | Millennium Pharmaceuticals, Inc. | Murine gene fomy030 coding for tumor progression inhibitor |
| US6794185B1 (en) | 1995-03-29 | 2004-09-21 | Millennium Pharmaceuticals, Inc. | fohy030 nucleic acid molecules |
| US6251597B1 (en) | 1996-03-29 | 2001-06-26 | Millennium Pharmaceuticals, Inc. | Methods for detecting fohy030 |
| US5783182A (en) * | 1996-01-30 | 1998-07-21 | Baylor College Of Medicine | Method for identifying metastatic sequences |
| WO1997018454A2 (en) * | 1995-11-16 | 1997-05-22 | Baylor College Of Medicine | Method for identifying metastatic sequences |
| USRE38490E1 (en) | 1995-11-16 | 2004-04-06 | Baylor College Of Medicine | Method for identifying metastatic sequences |
| JP2000504212A (ja) * | 1996-01-10 | 2000-04-11 | ザ・ユニバーシティ・オブ・リバプール | 転移誘発性ｄｎａ |
| USRE38392E1 (en) | 1996-01-30 | 2004-01-20 | Baylor College Of Medicine | Method for identifying metastatic sequences |
| US6312909B1 (en) | 1996-03-29 | 2001-11-06 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the diagnosis prevention and treatment of tumor progression |
| AU734476B2 (en) | 1997-11-05 | 2001-06-14 | Baylor College Of Medicine | Sequences for targeting metastatic cells |
| US6545139B1 (en) | 1998-03-13 | 2003-04-08 | Baylor College Of Medicine | DNA sequence encoding the p99 gene and kits for the detection of neoplasia |
| US7462491B2 (en) | 2002-01-31 | 2008-12-09 | Baylor College Of Medicine | Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin |
-
1985
- 1985-11-26 AU AU51979/86A patent/AU5197986A/en not_active Abandoned
- 1985-11-26 EP EP85906133A patent/EP0203970A1/en not_active Withdrawn
- 1985-11-26 FI FI863095A patent/FI863095L/fi not_active IP Right Cessation
- 1985-11-26 WO PCT/US1985/002323 patent/WO1986003226A1/en not_active Application Discontinuation
- 1985-11-26 HU HU8667A patent/HUT41837A/hu unknown
- 1985-11-26 JP JP60505382A patent/JPS62501399A/ja active Pending
- 1985-11-26 IL IL77157A patent/IL77157A0/xx unknown
- 1985-11-27 GR GR852864A patent/GR852864B/el unknown
- 1985-11-27 ZA ZA859070A patent/ZA859070B/xx unknown
- 1985-11-29 ES ES549438A patent/ES8705043A1/es not_active Expired
- 1985-11-29 PT PT81584A patent/PT81584B/pt unknown
-
1986
- 1986-07-29 DK DK359486A patent/DK359486D0/da not_active Application Discontinuation
- 1986-07-29 NO NO863066A patent/NO863066L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT81584A (en) | 1985-12-01 |
| ZA859070B (en) | 1986-07-30 |
| EP0203970A1 (en) | 1986-12-10 |
| IL77157A0 (en) | 1986-04-29 |
| ES549438A0 (es) | 1987-04-16 |
| FI863095A0 (fi) | 1986-07-29 |
| ES8705043A1 (es) | 1987-04-16 |
| GR852864B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1986-03-28 |
| FI863095A7 (fi) | 1986-07-29 |
| JPS62501399A (ja) | 1987-06-11 |
| HUT41837A (en) | 1987-05-28 |
| NO863066D0 (no) | 1986-07-29 |
| DK359486A (da) | 1986-07-29 |
| FI863095L (fi) | 1986-07-29 |
| WO1986003226A1 (en) | 1986-06-05 |
| PT81584B (en) | 1987-04-07 |
| NO863066L (no) | 1986-09-29 |
| AU5197986A (en) | 1986-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK359486A (da) | Overfoerbare pattedyrgener forbundet med tumormetastase, fremg. til isolering deraf, proteiner som generne koder for, antistoffer over for disse, sonder for generne og for mrna transkriberet derfra og fremg. til bedoemmelse af tumorers metastatiske tilboejelighed | |
| DK110885A (da) | Nucleinsyre-proteinkonjugater, disses anvendelse samt fremgangsmaade til fremstilling heraf | |
| DK73483A (da) | Dna-sekvenser, rekombinant-dna-molekyler samt fremgangsmaader til fremstilling af human-immune interferonlignende polypeptider | |
| NO891818D0 (no) | T4-reseptor-protein, relaterte dna-sekvenser samt fremstilling derav. | |
| DE3578190D1 (de) | Test fuer nukleinsaeuresequenzen, insbesondere genetische veraenderungen. | |
| FI871189A7 (fi) | Geenikoettimien parannuksia. | |
| DE3585953D1 (de) | Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine. | |
| DE68924227D1 (de) | DNA-Fragment. | |
| DK375283D0 (da) | Dna-sekvenser, rekombinations-dna-molekyler samt fremgangsmader til fremstilling af kvaegvaeksthormonlignende polypeptider | |
| DE3574994D1 (de) | Sandwichhybridisierungsverfahren zum nachweis von nukleotidsequenzen. | |
| NL188869B (nl) | Methode voor het bepalen van antigenen, alsmede testkit daarvoor. | |
| DK108589A (da) | Chimere antistoffer rettet mod humant carcinoembryonalt antigen samt dna-sekvenser, der koder for saadanne antistoffer | |
| AP9901654A0 (en) | Gene sequencer and methods. | |
| EP0284362A3 (en) | Molecular markers | |
| DK194886A (da) | Fremgangsmaade og system til supplering af salgsreoler med salgsartikler | |
| DE3764273D1 (de) | Kreiselpumpe zur foerderung heisser medien. | |
| FI883763L (fi) | Frigoering av vaerdens foersvarsmediatorer i biologiska vaetskor genom systematisk behandling med dubbelstraengat rna. | |
| NL193784B (nl) | Geïntegreerde brugschakeling, en werkwijze voor het vervaardigen daarvan. | |
| BR9912455A (pt) | ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória | |
| ZA975588B (en) | Isolated nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof. | |
| DE69738803D1 (de) | Apoptosis induzierendes protein und dieses kodierendes gen | |
| EP0226888A3 (en) | Monoclonal antibodies specific to galactosyltransferase isoenzyme ii and their use in cancer immunoassays | |
| DK352183A (da) | Fremgangsmaade og papir til rna-bestemmelse samt anvendelse af papiret | |
| DE3485923D1 (de) | Dna-gen, verfahren zu seiner herstellung und dieses gen enthaltendes plasmid. | |
| DE3789138D1 (de) | Nukleotid-Sequenzen, die selektiv exprimiert sind in pre-B-Zellen und Sonden zu diesem Zweck. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A0 | Application filed | ||
| AHB | Application shelved due to non-payment |